Madrigal Pharmaceuticals, Inc. (MDGL)
Nasdaq: MDGL · Pharmaceutical Preparations · West Conshohocken, PA · filing with the SEC since 2002
Who runs Madrigal Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Sibold William John
President and CEO. First filing Sep 2023, latest Sep 11, 2026, 9 filings in all.
Officers reporting now
8
of 20 people with a filing in the last fifteen months
Directors reporting now
12
36 people on the record since 2007
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kelley Shannon T | General Counsel | Aug 2024 | Nov 6, 2026 | 5 · $1.3M |
| Sibold William John | President and CEO | Sep 2023 | Sep 11, 2026 | 37 · $10.5M |
| Taub Rebecca | Pres., R&D, and CMO | Jul 2016 | Jun 18, 2026 | 42 · $21.7M |
| Soergel David | Chief Medical Officer | Apr 2025 | Jun 1, 2026 | 2 · $1.0M |
| Dier Mardi | EVP and CFO | Mar 2024 | Mar 6, 2026 | 28 · $3.8M |
| Huntsman Carole | Chief Commercial Officer | Nov 2023 | Mar 6, 2026 | 14 · $1.7M |
| Thakkar Rita | Chief Accounting Officer | Jan 2026 | Jan 20, 2026 | none |
| Friedman Paul A | Chief Executive Officer | Mar 2014 | Jan 13, 2026 | 38 · $26.7M |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| 667, L.P. | director | Jun 2023 | Nov 6, 2026 | none |
| Baker Bros. Advisors (Gp) LLC | director | Jun 2023 | Nov 6, 2026 | none |
| Baker Bros. Advisors LP | director | Jun 2023 | Nov 6, 2026 | none |
| Baker Brothers Life Sciences LP | director | Jun 2023 | Nov 6, 2026 | none |
| Baker Felix | director | Jun 2023 | Nov 6, 2026 | none |
| Baker Julian | director | Jun 2023 | Nov 6, 2026 | none |
| Reed John C | director | Aug 2026 | Aug 18, 2026 | none |
| Brennan Daniel J. | director | Aug 2025 | Jun 18, 2026 | none |
| Daly James M | director | Jul 2019 | Jun 18, 2026 | none |
| Fouse Jacqualyn A | director | Mar 2025 | Jun 18, 2026 | none |
| Levy Richard S | director | Nov 2016 | Jun 18, 2026 | 26 · $7.4M |
| Bate Kenneth | director | Jul 2016 | Nov 7, 2025 | none |
Earlier names on the record16, newest filing first
Craves Fred B · director · last filing Mar 2025Waltermire Robert E. · officer · last filing Mar 2025Howarth Alex G. · officer · last filing Jan 2024Lynch Brian Joseph · officer · last filing Jan 2024Cheong Raymond · director · last filing Jun 2023Sukhija Remy · officer · last filing Jan 2023Gollust Keith R · director · last filing Jun 2022Milligan David V · director · last filing Jun 2022Bay City Capital Fund IV Co Invesment Fund LP · director · last filing Dec 2021Bay City Capital Fund IV, L.P. · director · last filing Dec 2021Bay City Capital LLC · director · last filing Dec 2021Bay City Capital Management IV LLC · director · last filing Dec 2021Schneebaum Marc R · officer · last filing Feb 2021Schor Chen · officer · last filing Jul 2016Rieder Wendy E · officer · last filing Jul 2016Morenstein Scott D · director · last filing Jan 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.